Mandate

Vinge advises Industrifonden in connection with its investment in Keybroker

May 27, 2011

Vinge has advised Industrifonden in connection with its investment in Keybroker, one of the Nordic region's leading online marketing companies. Keybroker was founded in 2005 and has grown exponentially. The company currently has 50 employees and in 2010 its turnover amounted to SEK 180 million.
 
Industrifonden invests in small and medium sized Swedish companies with the potential for international expansion. The fund has access to approximately SEK 3 billion, SEK 1.5 billion of which is invested in approximately 90 companies within the technology, cleantech, life science and industrial sectors.
 
Vinge team consisted of Johan Larsson (project manager) together with fellow associates Malin Buch and Anna Möller. The responsible partner was Johan Winnerblad.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026